Hospira

Hospira

Rising Demand for Low-Calorie Sweeteners and Medical Applications Drives Global Dextrose Market Growth

Hospira, a global leader in injectable drugs and infusion technologies, is poised to benefit from the growing demand for medical applications of dextrose. According to a study by Evolve Business Intelligence, the global dextrose market size is expected to reach USD 5.9 billion by 2022. Hospira's expertise in injectable drugs and infusion technologies positions it well to capitalize on this growth.

In addition to medical applications, dextrose is also used as a low-calorie sweetener in food and beverages. As consumers continue to seek healthier alternatives to sugar, the demand for dextrose as a sweetener is expected to rise. Hospira's extensive portfolio of injectable drugs and infusion technologies, combined with its commitment to innovation, make it a strong player in both the medical and food industries.

Conclusion

Hospira's expertise in injectable drugs and infusion technologies, combined with the growing demand for medical applications and low-calorie sweeteners, position it well for continued growth in the global dextrose market. As the market continues to expand, Hospira's commitment to innovation and customer satisfaction make it a solid choice for investors looking to capitalize on this growth.